The Cold Chain Global Forum Spring is heading to San Diego, June 10-12. Join us for the event marries the technology and strategy needed to prepare for the future of supply chains while remaining compliant.
Inspirational Keynotes joining us at the event include:
- Scott Mooney, Vice President Distribution Operations, Supply Chain Assurance, McKesson Pharmaceutical
- Kevin Hickman, Senior Manager, Supply Chain Distribution, Gilead Sciences, Inc.
- Javier Gomez-Contreras, Head of Supply Chain Americas, GlaxoSmithKline (GSK)
- Chris J. Anderson, Director, Quality System, Cardinal Health
- Highlights an innovative partnership and solution to provide insulin access to patients in need, through free clinics and charitable pharmacies.
- Objective: Highlight considerations for both Lilly and Dispensary of Hope
Suzette Figueroa Diaz, Director Access & Affordability, Lilly Diabetes
Steve Stapleton, Director Patient Assistance Programs, Lilly USA & President Lilly Cares Foundation
Scott Cornwell, Chief Supply Chain Officer, Dispensary of Hope Eli Lilly and Company & Dispensary of Hope’s Partnership for Insulin Access
No country is immune to the problems associated with counterfeit medicines. Across the planet, governments are enforcing new regulations and directives to counter the threat of illegal pharmaceuticals to public health and safety.
In this report, ACG examines the EU’s Falsified Medicines Directive – due to be rolled out on February 9 next year.
This paper outlines the insights ACG have gained from their experience in Track & Trace implementation, highlights the challenges faced by pharmaceutical companies across the EU, and posits potential methods of overcoming them. With awareness of counterfeiting increasing, the pharmaceutical industry should be agile in the coming months, and learn to consider regulations as obligations in the years to come.
This whitepaper covers:
- IoT and blockchain will enable proactive shipment management. No longer will practitioners be restricted to post-shipment for analysis and excursion management, increasing the sector's ability to mitigate risk to the product and the patient.
- The future of the sector will be characterised by solutions that are software driven rather than hardware driven. The benefit of this is that logistics services and shippers will no longer be tied down to a single device, or group of devices that have restricted connectivity.
- A device-agnostic software system that can switch to the latest technology, which will put the shipper in a much more flexible position in terms of their purchasing ability. It will also ensure that the sector can maintain fluidity and adapt to newer technologies far easier than ever before.
A look into the concept of global standardization with risk management in the cold chain.
This whitepaper explores supply chain security and validation as they pertain to lane qualification, data monitoring, shipping lanes and stability budgets.
Get a sneak peek of who you can expect to meet and learn from at Cold Chain Spring!
Warehouse management systems (WMS) are all too often unable to comply with serialization requirements or deliver mandated reports due to their complexity and high degree of customization. In order to ensure compliance to DSCSA and FMD standards as well as more effectively control costs, companies need to invest in smarter inventory tracking and more efficient warehousing operations.
In this article, Larry Hall of Tracelink discusses how pharmaceutical serialization requirements are driving demand for smarter inventory tracking and warehouse management. In addition, Hall also provides use cases to highlight key considerations for ensuring life sciences warehousing operations are compliant.